Carregant...

Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma

The study goal was to assess the efficacy of combined EMMPRIN and DR5 targeted therapy for pancreatic adenocarcinoma in orthotopic mouse models using multi-modal imaging. Cytotoxicity of anti-EMMPRIN antibody and anti-DR5 antibody (TRA-8) in MIA PaCa-2 and PANC-1 cell lines was measured by ATPlite a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kim, Hyunki, Zhai, Guihua, Samuel, Sharon L., Rigell, Christopher J., Umphrey, Heidi R., Rana, Samir, Stockard, Cecil R., Fineberg, Naomi S., Zinn, Kurt R.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3277644/
https://ncbi.nlm.nih.gov/pubmed/22203731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-11-0581
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!